• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红细胞靶向抗原诱导的耐受性记忆及调节性T细胞的产生

Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens.

作者信息

Grimm Alizée J, Kontos Stephan, Diaceri Giacomo, Quaglia-Thermes Xavier, Hubbell Jeffrey A

机构信息

Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.

Anokion SA, Ecublens, Switzerland.

出版信息

Sci Rep. 2015 Oct 29;5:15907. doi: 10.1038/srep15907.

DOI:10.1038/srep15907
PMID:26511151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4625129/
Abstract

New approaches based on induction of antigen-specific immunological tolerance are being explored for treatment of autoimmunity and prevention of immunity to protein drugs. Antigens associated with apoptotic debris are known to be processed tolerogenically in vivo. Our group is exploring an approach toward antigen-specific tolerization using erythrocyte-binding antigens, based on the premise that as the erythrocytes circulate, age and are cleared, the erythrocyte surface-bound antigen payload will be cleared tolerogenically along with the eryptotic debris. Here, we characterized the phenotypic signatures of CD8+ T cells undergoing tolerance in response to soluble and erythrocyte-targeted antigen. Signaling through programmed death-1/programmed death ligand-1 (PD-1/PD-L1), but not through cytotoxic T lymphocyte antigen 4 (CTLA4), was shown to be required for antigen-specific T cell deletion, anergy and expression of regulatory markers. Generation of CD25+FOXP3+ regulatory T cells in response to erythrocyte-targeted antigens but not soluble antigen at an equimolar dose was observed, and these cells were required for long-term maintenance of immune tolerance in both the CD4+ and CD8+ T cell compartments. Evidence of infectious tolerance was observed, in that tolerance to a one antigenic epitope was able to regulate responses to other epitopes in the same protein antigen.

摘要

基于诱导抗原特异性免疫耐受的新方法正在被探索用于自身免疫性疾病的治疗以及预防对蛋白质药物的免疫反应。已知与凋亡碎片相关的抗原在体内以耐受性方式被加工处理。我们的研究小组正在探索一种利用红细胞结合抗原实现抗原特异性耐受的方法,其前提是随着红细胞循环、老化并被清除,红细胞表面结合的抗原负载将与凋亡碎片一起以耐受性方式被清除。在此,我们对响应可溶性抗原和红细胞靶向抗原而发生耐受的CD8 + T细胞的表型特征进行了表征。结果显示,抗原特异性T细胞的缺失、无反应性以及调节性标志物的表达需要通过程序性死亡-1/程序性死亡配体-1(PD-1/PD-L1)信号通路,而不是通过细胞毒性T淋巴细胞抗原4(CTLA4)信号通路。观察到在等摩尔剂量下,响应红细胞靶向抗原而非可溶性抗原可产生CD25 + FOXP3 +调节性T细胞,并且这些细胞是CD4 +和CD8 + T细胞区室中免疫耐受长期维持所必需的。观察到了感染性耐受的证据,即对一个抗原表位的耐受能够调节对同一蛋白质抗原中其他表位的反应。

相似文献

1
Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens.红细胞靶向抗原诱导的耐受性记忆及调节性T细胞的产生
Sci Rep. 2015 Oct 29;5:15907. doi: 10.1038/srep15907.
2
Engineering antigens for in situ erythrocyte binding induces T-cell deletion.工程抗原原位结合红细胞诱导 T 细胞缺失。
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):E60-8. doi: 10.1073/pnas.1216353110. Epub 2012 Dec 17.
3
CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.CD8+ 树突状细胞介导的自身反应性 CD4+ T 细胞耐受在 NOD 小鼠中缺陷,并可通过阻断 CD40L 来纠正。
J Leukoc Biol. 2014 Feb;95(2):325-36. doi: 10.1189/jlb.0113013. Epub 2013 Sep 30.
4
Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.阻断程序性死亡-1 在年轻(新西兰黑 x 新西兰白)F1 小鼠中促进了抑制性 CD8+T 细胞的活性,从而保护其免受狼疮样疾病的侵害。
J Immunol. 2010 Dec 1;185(11):6563-71. doi: 10.4049/jimmunol.0903401. Epub 2010 Nov 1.
5
Maternal CD4⁺ and CD8⁺ T cell tolerance towards a fetal minor histocompatibility antigen in T cell receptor transgenic mice.母体 CD4+ 和 CD8+ T 细胞对 T 细胞受体转基因小鼠中胎儿次要组织相容性抗原的耐受。
Biol Reprod. 2013 Oct 31;89(4):102. doi: 10.1095/biolreprod.113.110445. Print 2013 Oct.
6
Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway.同种异体反应性CD8而非CD4 T细胞的外周删除性耐受依赖于PD-1/PD-L1途径。
Blood. 2008 Sep 1;112(5):2149-55. doi: 10.1182/blood-2007-12-127449. Epub 2008 Jun 24.
7
Split peripheral tolerance: CD40 ligation blocks tolerance induction for CD8 T cells but not for CD4 T cells in response to intestinal antigens.分裂外周耐受:CD40 连接阻断了 CD8 T 细胞对肠道抗原的耐受诱导,但对 CD4 T 细胞则没有。
Eur J Immunol. 2005 May;35(5):1381-90. doi: 10.1002/eji.200425819.
8
Neonatal tolerance to a Th2-mediated autoimmune disease generates CD8+ Tc1 regulatory cells.新生儿对Th2介导的自身免疫性疾病的耐受性会产生CD8 + Tc1调节性细胞。
J Autoimmun. 2003 Nov;21(3):201-12. doi: 10.1016/s0896-8411(03)00118-5.
9
Low-avidity CD8lo T cells induced by incomplete antigen stimulation in vivo regulate naive higher avidity CD8hi T cell responses to the same antigen.体内不完全抗原刺激诱导产生的低亲和力CD8lo T细胞可调节初始高亲和力CD8hi T细胞对相同抗原的反应。
Eur J Immunol. 2006 Feb;36(2):397-410. doi: 10.1002/eji.200535064.
10
Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance.淋巴结靶向合成糖基化抗原导致抗原特异性免疫耐受。
Front Immunol. 2021 Sep 24;12:714842. doi: 10.3389/fimmu.2021.714842. eCollection 2021.

引用本文的文献

1
Antigen-specific immunotherapies for autoimmune disease.用于自身免疫性疾病的抗原特异性免疫疗法。
Nat Rev Rheumatol. 2025 Feb;21(2):88-97. doi: 10.1038/s41584-024-01201-w. Epub 2024 Dec 16.
2
RBC-hitchhiking PLGA nanoparticles loading β-glucan as a delivery system to enhance and immune responses in mice.负载β-葡聚糖的红细胞搭载聚乳酸-羟基乙酸共聚物纳米颗粒作为递送系统以增强小鼠免疫反应
Front Vet Sci. 2024 Sep 16;11:1462518. doi: 10.3389/fvets.2024.1462518. eCollection 2024.
3
Biomaterial-enhanced treg cell immunotherapy: A promising approach for transplant medicine and autoimmune disease treatment.

本文引用的文献

1
Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase.与红细胞的工程化结合可诱导对大肠杆菌天冬酰胺酶的免疫耐受。
Sci Adv. 2015 Jul 17;1(6):e1500112. doi: 10.1126/sciadv.1500112. eCollection 2015 Jul.
2
Engineering antigen-specific immunological tolerance.工程化抗原特异性免疫耐受
Curr Opin Immunol. 2015 Aug;35:80-8. doi: 10.1016/j.coi.2015.05.005. Epub 2015 Jul 8.
3
Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens.变应原特异性免疫疗法及对变应原的免疫耐受机制。
生物材料增强的调节性T细胞免疫疗法:移植医学和自身免疫性疾病治疗的一种有前景的方法。
Bioact Mater. 2024 Apr 22;37:269-298. doi: 10.1016/j.bioactmat.2024.03.030. eCollection 2024 Jul.
4
New Developments in Celiac Disease Treatment.乳糜泻治疗的新进展。
Int J Mol Sci. 2023 Jan 4;24(2):945. doi: 10.3390/ijms24020945.
5
Perspective on the Application of Erythrocyte Liposome-Based Drug Delivery for Infectious Diseases.基于红细胞脂质体的药物递送在传染病治疗中的应用前景
Membranes (Basel). 2022 Dec 3;12(12):1226. doi: 10.3390/membranes12121226.
6
Engineered red blood cells (activating antigen carriers) drive potent T cell responses and tumor regression in mice.工程化红细胞(激活抗原载体)可在小鼠中引发强烈的 T 细胞反应和肿瘤消退。
Front Immunol. 2022 Oct 3;13:1015585. doi: 10.3389/fimmu.2022.1015585. eCollection 2022.
7
Chemical Conjugation in Drug Delivery Systems.药物递送系统中的化学偶联
Front Chem. 2022 May 26;10:889083. doi: 10.3389/fchem.2022.889083. eCollection 2022.
8
Engineering Islets From Stem Cells: The Optimal Solution for the Treatment of Diabetes?从干细胞中工程化胰岛:治疗糖尿病的最佳方案?
Front Immunol. 2022 Apr 27;13:869514. doi: 10.3389/fimmu.2022.869514. eCollection 2022.
9
Hybrid red blood cell membrane coated porous silicon nanoparticles functionalized with cancer antigen induce depletion of T cells.用癌症抗原功能化的杂交红细胞膜包被的多孔硅纳米颗粒可诱导T细胞耗竭。
RSC Adv. 2020 Sep 23;10(58):35198-35205. doi: 10.1039/d0ra05900e. eCollection 2020 Sep 21.
10
Harnessing the liver to induce antigen-specific immune tolerance.利用肝脏诱导抗原特异性免疫耐受。
Semin Immunopathol. 2022 Jul;44(4):475-484. doi: 10.1007/s00281-022-00942-8. Epub 2022 May 5.
World Allergy Organ J. 2015 May 14;8(1):17. doi: 10.1186/s40413-015-0063-2. eCollection 2015.
4
Insulin B chain 9-23 gene transfer to hepatocytes protects from type 1 diabetes by inducing Ag-specific FoxP3+ Tregs.胰岛素 B 链 9-23 基因转染肝细胞通过诱导 Ag 特异性 FoxP3+Tregs 保护免受 1 型糖尿病。
Sci Transl Med. 2015 May 27;7(289):289ra81. doi: 10.1126/scitranslmed.aaa3032.
5
Current and emerging therapy for celiac disease.当前和新兴的乳糜泻治疗方法。
Front Med (Lausanne). 2014 Mar 24;1:6. doi: 10.3389/fmed.2014.00006. eCollection 2014.
6
Of macrophages and red blood cells; a complex love story.巨噬细胞与红细胞之间;一段复杂的“爱情故事”。
Front Physiol. 2014 Jan 30;5:9. doi: 10.3389/fphys.2014.00009. eCollection 2014.
7
Exploiting apoptosis for therapeutic tolerance induction.利用细胞凋亡诱导治疗性耐受。
J Immunol. 2013 Dec 1;191(11):5341-6. doi: 10.4049/jimmunol.1302070.
8
Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders.特普利珠单抗(抗 CD3 mAb)治疗在随机对照试验中可保留新诊断 1 型糖尿病患者的 C 肽反应:基线时的代谢和免疫特征可识别出应答者亚组。
Diabetes. 2013 Nov;62(11):3766-74. doi: 10.2337/db13-0345. Epub 2013 Jul 8.
9
Transdermal application of myelin peptides in multiple sclerosis treatment.多发性硬化症治疗中的髓鞘肽经皮给药。
JAMA Neurol. 2013 Sep 1;70(9):1105-9. doi: 10.1001/jamaneurol.2013.3022.
10
Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetes.质粒编码的胰岛素原在保留 C 肽的同时,特异性减少 1 型糖尿病中胰岛素原特异性 CD8⁺ T 细胞。
Sci Transl Med. 2013 Jun 26;5(191):191ra82. doi: 10.1126/scitranslmed.3006103.